ProfileGDS4718 / 229718_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 57% 49% 60% 51% 55% 57% 51% 54% 59% 57% 56% 53% 50% 52% 54% 58% 60% 48% 50% 55% 52% 55% 66% 60% 57% 56% 56% 62% 55% 49% 55% 55% 52% 57% 56% 66% 49% 56% 56% 60% 58% 66% 49% 63% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]5.938157
GSM549102patient 115, normal, homogenized [OPG study]5.4918949
GSM549104patient 119, normal, homogenized [OPG study]6.178660
GSM549108patient 138, normal, homogenized [OPG study]5.6000851
GSM549119patient 077, normal, homogenized [OPG study]5.8330455
GSM549133patient 032, cancer, homogenized [OPG study]5.9039157
GSM549139patient 042, cancer, homogenized [OPG study]5.5421551
GSM549099patient 107, normal, homogenized [OPG study]5.7535754
GSM549109patient 139, normal, homogenized [OPG study]6.0618259
GSM549110patient 046, normal, homogenized [OPG study]5.9371957
GSM549114patient 063, normal, homogenized [OPG study]5.8318656
GSM549122patient 082, normal, homogenized [OPG study]5.6913553
GSM549134patient 033, cancer, homogenized [OPG study]5.5129950
GSM549136patient 036, cancer, homogenized [OPG study]5.6048752
GSM549140patient 044, cancer, homogenized [OPG study]5.7394354
GSM549111patient 047, normal, homogenized [OPG study]6.0150258
GSM549113patient 057, normal, homogenized [OPG study]6.0883660
GSM549132patient 031, cancer, homogenized [OPG study]5.4176248
GSM549137patient 038, cancer, homogenized [OPG study]5.5271550
GSM549142patient 047, cancer, homogenized [OPG study]5.9120255
GSM549100patient 110, normal, homogenized [OPG study]5.6548552
GSM549107patient 135, normal, homogenized [OPG study]5.7753855
GSM549115patient 068, normal, homogenized [OPG study]6.5511266
GSM549116patient 072, normal, homogenized [OPG study]6.1159960
GSM549120patient 078, normal, homogenized [OPG study]5.941857
GSM549131patient 030, cancer, homogenized [OPG study]5.8485456
GSM549118patient 074, normal, homogenized [OPG study]5.8788156
GSM549129patient 027, cancer, homogenized [OPG study]6.2775762
GSM549123patient 088, normal, homogenized [OPG study]5.8147455
GSM549124patient 006, cancer, homogenized [OPG study]5.4574149
GSM549126patient 015, cancer, homogenized [OPG study]5.8248155
GSM549128patient 025, cancer, homogenized [OPG study]5.8397655
GSM549103patient 117, normal, homogenized [OPG study]5.6712652
GSM549117patient 073, normal, homogenized [OPG study]5.8732857
GSM549138patient 041, cancer, homogenized [OPG study]5.8708156
GSM549141patient 045, cancer, homogenized [OPG study]6.5817866
GSM549130patient 028, cancer, homogenized [OPG study]5.4346349
GSM549101patient 111, normal, homogenized [OPG study]5.8810456
GSM549105patient 128, normal, homogenized [OPG study]5.8963756
GSM549106patient 134, normal, homogenized [OPG study]6.144760
GSM549112patient 048, normal, homogenized [OPG study]5.9947458
GSM549125patient 011, cancer, homogenized [OPG study]6.523866
GSM549127patient 024, cancer, homogenized [OPG study]5.4545849
GSM549135patient 035, cancer, homogenized [OPG study]6.3047763